Persistently low plasma thioredoxin is associated with meningococcal septic shock in children

被引:9
作者
Callister, Matthew E.
Burke-Gaffney, Anne [1 ]
Quinlan, Gregory J.
Betts, Helen
Nadel, Simon
Evans, Timothy W.
机构
[1] Royal Brompton Hosp, Crit Care Unit, Natl Heart & Lung Inst, Imperial Coll,Fac Med, London SW3 61Y, England
[2] St Marys Hosp, Imperial Coll, Dept Paediat, London, England
基金
英国惠康基金;
关键词
meningococcal infection; sepsis syndrome; systemic inflammatory response syndrome; thioredoxin; oxidation-reduction; cytokines;
D O I
10.1007/s00134-006-0460-7
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To compare plasma levels of thioredoxin (Trx), TNF-alpha and IL-1 beta in children during the acute phase of meningococcal septic shock (MSS) and in convalescence. Design and setting: Retrospective, observational study in the paediatric intensive care unit of a postgraduate teaching hospital. Patients: Thirty-five children requiring intensive care for meningococcal sepsis; paired convalescent samples from 30 survivors (median interval between samples 62 days); 25 healthy control children. Measurements and results: Plasma Trx levels were significantly lower in the children with MSS, both during the acute illness (5.5 ng/ml, IQR 1.4-11.4) and in convalescence (2.5 ng/ml, IQR 0.4-6.9) than controls (18.8 ng/ml, IQR 7.9-25.0). Levels of IL-1 beta and TNF-alpha were higher in patients with acute MSS (30.3 pg/ml, IQR 3.6-63.6, and 145.9 pg/ml, IQR 31.8-278.1 respectively) than controls (3.7 pg/ml, IQR 0-36.9, and 23.8 pg/ml, IQR 0-124.3, respectively). Levels fell in convalescence (3.7 pg/ml, IQR 0-25.5, 3.7 pg/ml, IQR 0-304.8, respectively). Plasma Trx was higher in non-survivors, albeit a small group (n = 5), than in survivors (n = 30). Trx, IL-1 beta, and TNF-alpha levels were not correlated with predicted mortality as assessed by the paediatric risk of mortality (PRISM) score. Conclusions: Children with MSS exhibit persistently low plasma levels of Trx during acute illness and in convalescence.
引用
收藏
页码:364 / 367
页数:4
相关论文
共 14 条
[1]   Thioredoxin: friend or foe in human disease? [J].
Burke-Gaffney, A ;
Callister, MEJ ;
Nakamura, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (08) :398-404
[2]   Extracellular thioredoxin levels are increased in patients with acute lung injury [J].
Callister, M. E. ;
Burke-Gaffney, A. ;
Quinlan, G. J. ;
Nicholson, A. G. ;
Florio, R. ;
Nakamura, H. ;
Yodoi, J. ;
Evans, T. W. .
THORAX, 2006, 61 (06) :521-527
[3]   Expression of thioredoxin and thioredoxin reductase in placentae of pregnant mice exposed to lipopolysaccharide [J].
Ejima, K ;
Koji, T ;
Nanri, H ;
Kashimura, M ;
Ikeda, M .
PLACENTA, 1999, 20 (07) :561-566
[4]   Antioxidant protection against iron in children with meningococcal sepsis [J].
Festa, M ;
Mumby, S ;
Nadel, S ;
Gutteridge, JMC ;
Quinlan, GJ .
CRITICAL CARE MEDICINE, 2002, 30 (07) :1623-1629
[5]   TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 IN THE SERUM OF CHILDREN WITH SEVERE INFECTIOUS PURPURA [J].
GIRARDIN, E ;
GRAU, GE ;
DAYER, JM ;
ROUXLOMBARD, P ;
LAMBERT, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (07) :397-400
[6]   The thioredoxin system - From science to clinic [J].
Gromer, S ;
Urig, S ;
Becker, K .
MEDICINAL RESEARCH REVIEWS, 2004, 24 (01) :40-89
[7]   RELATION BETWEEN CYTOKINES AND ROUTINE LABORATORY DATA IN CHILDREN WITH SEPTIC SHOCK AND PURPURA [J].
HAZELZET, JA ;
VANDERVOORT, E ;
LINDEMANS, J ;
TERHEERDT, PGJ ;
NEIJENS, HJ .
INTENSIVE CARE MEDICINE, 1994, 20 (05) :371-374
[8]   4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease [J].
Hermans, PWM ;
Hibberd, ML ;
Booy, R ;
Daramola, O ;
Hazelzet, JA ;
de Groot, R ;
Levin, M .
LANCET, 1999, 354 (9178) :556-560
[9]   TISSUE DISTRIBUTION AND SUBCELLULAR-LOCALIZATION OF BOVINE THIOREDOXIN DETERMINED BY RADIOIMMUNOASSAY [J].
HOLMGREN, A ;
LUTHMAN, M .
BIOCHEMISTRY, 1978, 17 (19) :4071-4077
[10]   High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis [J].
Lemarechal, H ;
Allanore, Y ;
Chenevier-Gobeaux, C ;
Ekindjian, OG ;
Kahan, A ;
Bordenie, D .
CLINICA CHIMICA ACTA, 2006, 367 (1-2) :156-161